Investors, Pernix Set $75M Stalking Horse Bid For Orexigen
The bankrupt obesity-drug maker Orexigen Therapeutics Inc. on Monday said it will likely sell its business to Nalpropion Pharmaceuticals, which was just formed by an investor group and Pernix Therapeutics Holdings...To view the full article, register now.
Already a subscriber? Click here to view full article